TipRanks
MeVis Medical Solutions AG (DE:M3V)
XETRA:M3V
Germany Market
M3V
MeVis Medical Solutions
RESEARCH TOOLSreports
Want to see DE:M3V full AI Analyst Report?

MeVis Medical Solutions (M3V) Ratios

3 Followers

MeVis Medical Solutions Ratios

DE:M3V's free cash flow for Q2 2026 was €0.15. For the 2026 fiscal year, DE:M3V's free cash flow was decreased by € and operating cash flow was €<0.01. See a summary of the company’s cash flow.
Ratios
TTM
Sep 25Sep 24Sep 23Sep 22
Liquidity Ratios
Current Ratio
 2.27 1.58 1.50 1.66 1.50
Quick Ratio
 2.27 1.58 1.50 1.66 1.49
Cash Ratio
 1.25 1.14 1.03 1.13 0.96
Solvency Ratio
 0.44 0.41 0.54 0.49 0.59
Operating Cash Flow Ratio
 0.00 0.68 0.49 0.85 0.50
Short-Term Operating Cash Flow Coverage
 0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
€ 1.31M€ 992.23K€ 890.18K€ 1.14M€ 1.13M
Leverage Ratios
Debt-to-Assets Ratio
 0.00 0.00 0.00 0.00 0.00
Debt-to-Equity Ratio
 0.00 0.00 0.00 0.00 0.00
Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.30 1.45 1.49 1.57 1.75
Debt Service Coverage Ratio
 0.00 5.74K 239.22 118.12 0.00
Interest Coverage Ratio
 0.00 4.06K 204.00 150.47 0.00
Debt to Market Cap
 0.00 0.00 0.00 0.00 0.00
Interest Debt Per Share
 0.00 <0.01 0.01 0.02 0.00
Net Debt to EBITDA
 -2.76 -1.90 -1.35 -1.50 -1.17
Profitability Margins
Gross Profit Margin
22.90%97.70%97.11%40.38%96.02%
EBIT Margin
7.41%20.42%27.73%29.27%42.00%
EBITDA Margin
8.31%21.33%28.40%29.83%42.48%
Operating Profit Margin
19.14%14.58%23.58%37.16%33.53%
Pretax Profit Margin
14.53%20.41%27.62%29.03%41.98%
Net Profit Margin
13.88%19.71%26.87%28.37%41.52%
Continuous Operations Profit Margin
13.88%19.71%26.87%28.37%41.52%
Net Income Per EBT
95.52%96.56%97.30%97.73%98.89%
EBT Per EBIT
75.89%140.02%117.12%78.12%125.21%
Return on Assets (ROA)
9.52%12.23%17.22%17.54%24.96%
Return on Equity (ROE)
12.34%17.76%25.59%27.60%43.69%
Return on Capital Employed (ROCE)
15.03%11.61%19.89%30.39%29.22%
Return on Invested Capital (ROIC)
14.36%11.21%19.44%29.70%28.90%
Return on Tangible Assets
9.52%12.23%17.22%17.54%24.96%
Earnings Yield
5.22%7.01%10.90%9.52%12.51%
Efficiency Ratios
Receivables Turnover
 5.82 7.05 6.14 6.54 3.85
Payables Turnover
 162.52 2.57 5.73 134.73 3.88
Inventory Turnover
 0.00 0.00 0.00 0.00 5.59
Fixed Asset Turnover
 54.03 52.02 53.84 118.73 115.80
Asset Turnover
 0.69 0.62 0.64 0.62 0.60
Working Capital Turnover Ratio
 3.93 4.92 4.40 3.71 4.16
Cash Conversion Cycle
 60.43 -90.44 -4.27 53.11 65.86
Days of Sales Outstanding
 62.68 51.78 59.46 55.81 94.76
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 65.24
Days of Payables Outstanding
 2.25 142.22 63.74 2.71 94.15
Operating Cycle
 62.68 51.78 59.46 55.81 160.00
Cash Flow Ratios
Operating Cash Flow Per Share
 0.00 2.13 1.73 3.22 2.67
Free Cash Flow Per Share
 0.00 2.05 1.56 3.17 2.60
CapEx Per Share
 0.00 0.08 0.17 0.04 0.07
Free Cash Flow to Operating Cash Flow
 0.00 0.96 0.90 0.99 0.97
Dividend Paid and CapEx Coverage Ratio
 0.00 0.83 0.60 0.74 1.04
Capital Expenditure Coverage Ratio
 0.00 27.62 10.42 73.44 36.49
Operating Cash Flow Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Sales Ratio
 0.00 0.24 0.19 0.34 0.26
Free Cash Flow Yield
0.00%8.28%6.80%11.17%7.59%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 19.17 14.25 9.18 10.51 7.99
Price-to-Sales (P/S) Ratio
 2.66 2.81 2.47 2.98 3.32
Price-to-Book (P/B) Ratio
 2.37 2.53 2.35 2.90 3.49
Price-to-Free Cash Flow (P/FCF) Ratio
 0.00 12.07 14.72 8.95 13.18
Price-to-Operating Cash Flow Ratio
 0.00 11.64 13.30 8.83 12.81
Price-to-Earnings Growth (PEG) Ratio
 -0.29 -0.46 -1.30 -0.28 0.11
Price-to-Fair Value
 2.37 2.53 2.35 2.90 3.49
Enterprise Value Multiple
 29.20 11.27 7.33 8.50 6.64
Enterprise Value
 38.57M 38.61M 35.33M 43.94M 52.92M
EV to EBITDA
 29.20 11.27 7.33 8.50 6.64
EV to Sales
 2.43 2.40 2.08 2.53 2.82
EV to Free Cash Flow
 0.00 10.33 12.42 7.61 11.20
EV to Operating Cash Flow
 0.00 9.95 11.23 7.51 10.90
Tangible Book Value Per Share
 9.79 9.79 9.79 9.79 9.79
Shareholders’ Equity Per Share
 9.79 9.79 9.79 9.79 9.79
Tax and Other Ratios
Effective Tax Rate
 0.04 0.03 0.03 0.02 0.01
Revenue Per Share
 8.73 8.82 9.33 9.53 10.31
Net Income Per Share
 1.21 1.74 2.51 2.70 4.28
Tax Burden
 0.96 0.97 0.97 0.98 0.99
Interest Burden
 1.96 1.00 1.00 0.99 1.00
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.04 0.03 0.03 0.03 0.02
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.00 1.23 0.69 1.19 0.62
Currency in EUR